Skip to main content
PLOS Digital Health logoLink to PLOS Digital Health
. 2025 Apr 8;4(4):e0000818. doi: 10.1371/journal.pdig.0000818

Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemic

Jack D Watson 1,2, Bridget Xia 3, Mia E Dini 4, Alexandra L Silverman 5, Bradford S Pierce 6, Chi-Ning Chang 7, Paul B Perrin 3,4,*
Editor: Calvin Or8
PMCID: PMC11977993  PMID: 40198620

Abstract

Despite decades of low utilization, telemedicine adoption expanded at an unprecedented rate during the COVID-19 pandemic. This study examined quantitative and qualitative data provided by a national online sample of 228 practicing physicians (64% were women, and 75% were White) to identify facilitators and barriers to the adoption of telemedicine in the United States (U.S.) at the beginning of the COVID-19 pandemic. Logistic regressions were used to predict the most frequently endorsed (20% or more) barriers and facilitators based on participant demographics and practice characteristics. The top five reported barriers were: lack of patient access to technology (77.6%), insufficient insurance reimbursement (53.5%), diminished doctor-patient relationship (46.9%), inadequate video/audio technology (46.1%), and diminished quality of delivered care (42.1%). The top five reported facilitators were: better access to care (75.4%), increased safety (70.6%), efficient use of time (60.5%), lower cost for patients (43%), and effectiveness (28.9%). Physicians’ demographic and practice setting characteristics significantly predicted their endorsement of telemedicine barriers and facilitators. Older physicians were less likely to endorse inefficient use of time (p < 0.001) and potential for medical errors (p = 0.034) as barriers to telemedicine use compared to younger physicians. Physicians working in a medical center were more likely to endorse inadequate video/audio technology (p = 0.037) and lack of patient access to technology (p = 0.035) as a barrier and more likely to endorse lower cost for patients as a facilitator (p = 0.041) than providers working in other settings. Male physicians were more likely to endorse inefficient use of time as a barrier (p = 0.007) than female physicians, and White physicians were less likely to endorse lower costs for patients as a facilitator (p = 0.012) than physicians of color. These findings provide important context for future implementation strategies for healthcare systems attempting to increase telemedicine utilization.

Author summary

Many physicians treated patients via telemedicine to maintain social distancing during the COVID-19 pandemic. We surveyed a group of U.S. physicians to identify barriers and facilitators of using telemedicine at the beginning of the pandemic. Lack of patient access to technology necessary for telemedicine was the top barrier reported by the physicians. Improving patient access to care was the top facilitator. We also found that the physicians’ age, gender, race, and practice setting influenced their opinions. Older physicians were less likely to report wasting time (such as troubleshooting technological issues) and increased possibility of making medical errors as barriers than younger physicians. Male physicians were more likely to report wasting time (such as troubleshooting technological issues) as a barrier than female physicians. White physicians were less likely to report cheaper cost as a facilitator than minority physicians. Physicians working in a medical center were more likely to report poor quality of telemedicine technology and lack of patient access to technology necessary for telemedicine as barriers and cheaper cost for patients as a facilitator. These findings may be helpful for healthcare systems to consider when implementing telemedicine practice in the future.

Introduction

The World Health Organization (WHO) declared a pandemic related to a new strain of the coronavirus (COVID-19) in mid-March of 2020 [1]. Government entities, businesses, and other institutions (e.g., healthcare systems) sought ways to prevent the spread of infection, keep their employees and patrons safe, and comply with new pandemic-related regulations for social distancing and lockdowns [2]. One key strategy adopted by many institutions was a rapid shift to online technologies; much of what was once done in person was now conducted virtually [3].

Healthcare, especially, saw a significant and swift change. Elective procedures and routine care were postponed while healthcare systems were predicted to be overwhelmed by COVID-19 patients; medical supplies were scarce, and front-line healthcare workers were placed at increased risk for COVID-19 exposure [4]. Several major healthcare groups including the Veterans Health Administration and the Mayo Clinic Health System promptly converted to providing a large portion of their care through telemedicine, a means of delivering healthcare services remotely using a telecommunication device often connected via internet (e.g., computer, tablet, or phone) [58].

During the early stages of the COVID-19 pandemic, telemedicine emergency room visits increased by 50% compared to the same period in 2019 and, by the end of March, increased by a staggering 154% [9]. However, this rapid change may have been driven more from necessity than provider preference or enthusiasm for telemedicine. Indeed, as little as 3.72% of all clinical work prior to the pandemic was delivered via telemedicine [10], and clinician attitudes for and acceptance of (or lack thereof) telemedicine was the most significant factor predicting telemedicine uptake [11].

A growing body of literature has highlighted the efficacy of telemedicine treatment and its importance amidst the changing healthcare landscape [1012]. While many healthcare providers reported satisfaction with telemedicine and a general willingness to continue using the modality [11], some research has indicated a predicted post-pandemic decrease in telemedicine use among physicians [10]. Indeed, the mainstream use of telemedicine hinges heavily on clinician enthusiasm for the modality and removing barriers to its implementation while highlighting its numerous advantages [13]. Thus, it is important to understand what variables during the pandemic facilitated or impeded the use of telemedicine as well as potential implications for implementation and clinical use.

The growing literature on telemedicine has demonstrated a number of factors instrumental in determining attitudes, perceptions, and uptake of telemedicine delivery. Prior telemedicine education and experience have been linked to more favorable opinions of telemedicine [11,14,15]; however, this may be due more to repeated use and familiarity with telemedicine than training [10]. Reliable and flexible technology, dedicated resources for telemedicine, appropriate training, supportive leadership attitudes, and increased access to care have all been cited as factors contributing to more positive attitudes toward telemedicine [10,12,16,17]. Conversely, higher cost, lack of familiarity with technology, inequitable access, unsupportive regulations, and reimbursement issues have all been connected with reticence toward telemedicine [10,12,16,17].

Thus, the current study examined quantitative and qualitative data provided by 228 practicing physicians to identify barriers and facilitators to the adoption of telemedicine in the U.S. at the beginning of the COVID-19 pandemic. Physicians’ personal and practice characteristics were also collected to help identify which characteristics were associated with the likelihood to endorse a specific barrier or facilitator to telemedicine use.

Methods

Participants

Physicians of all specialties were recruited across the U.S., irrespective of specific geographic location within the U.S. Physicians were invited by email to participate in the study using directories of hospital and health clinic websites, professional organizations, social media groups, and professional newsgroups. Data were collected over 11 weeks from 12 May 2020–25 July 2020. Eligibility requirements were: (a) 18 years of age or older and (b) licensed and practicing (i.e., actively seeing patients) as a physician in the U.S. A total of 850 individuals were contacted via email to participate (with invitations also posted to online groups of physicians). Forty-six invitations returned as undeliverable. A total of 315 people (39.2% of those invited) opened the survey, with 21 leaving after viewing the information sheet. Participant data were reviewed to determine eligibility and missingness (with incomplete data or those not meeting eligibility deleted) for a total sample size of 228, licensed, practicing physicians. This response rate is acceptable for studies using similar methods of recruitment techniques [18,19]. Data for the current study were collected as part of a larger study [10]. The initial invitation was crafted to avoid indicating the study’s focus on telemedicine to reduce self-selection bias. Telemedicine was defined as “the use of real-time audio (e.g., telephone) and/or video conferencing technology to provide medical services.”

Ethics statement

The study was approved by the Virginia Commonwealth University Institutional Review Board (IRB) under protocol HM20019315 to ensure it was conducted ethically and in compliance with all federal, state, and local regulations concerning research involving human participants. Because the study was designated exempt by the IRB, an information form was presented to participants rather than an informed consent document.

Measures

Participants were asked to provide demographic (e.g., age, gender, race) and practice-related (e.g., medical specialty, location, population density) information. They were asked to respond to several questions regarding their telemedicine use and select any “advantages or incentives for using telemedicine in your practice to treat patients” and “barriers or deterrents to telemedicine in your practice to treat patients.” The list of questions regarding demographic and practice characteristics (i.e., the predictors for the current study) were based on previous literature on telemedicine and telepsychology barriers, facilitators, or use. S1 Table appendix provides the survey responses.

Within the survey, the selectable options of advantages/barriers were researcher-generated from the previous literature on telemedicine barriers, facilitators, and the likelihood of use [1012,1417]. Similarly, all sociodemographic or practice characteristics were selected due to previous research indicating potential relationships with telemedicine use [1012,1417]. The final list of barriers and facilitators, including both the initial researcher-generated selectable options and the additional categories added during the qualitative analysis, can be seen in S1 Table.

Data analysis

All analyses were conducted in R [20]. Descriptive statistics were calculated with percentages indicating the proportion of physicians who endorsed the various barriers and facilitators of telemedicine use. Endorsement of barriers and facilitators was defined as survey respondents choosing each option with select-all-that-apply. The options not selected were automatically considered as not endorsed by the respondents. We then ran a series of logistic regressions to predict, using participant demographics and practice characteristics, the most frequently endorsed (20% or more) barriers and facilitators with not endorsing the barrier or facilitator as the reference category. Predictors included the continuous variable age and binary variables of gender (man vs. woman), race (White/European American race/ethnicity vs. non-White individuals), medical practice settings (medical center vs. all other settings), and geographic location (urban vs. suburban and rural). For these groupings, medical center was defined as either an academic medical center or a Department of Veterans Affairs medical center, and suburban physicians were grouped with rural physicians primarily due to the sample size in an attempt to detect unique features related to urbanicity (as opposed to rural and suburban characteristics). The reference groups for these binary variables were woman, non-White individuals, all other settings, and suburban and rural areas, respectively. Chi-squared and Nagelkerke pseudo-R squared statistics were calculated to test the overall significance of the logistic regression models with all predictor variables.

To appropriately code the qualitative “other” responses for both advantages/facilitators and barriers/deterrents, we conducted a content analysis of the participants’ responses [21] that is similar to descriptive content methods used in prior qualitative research on barriers and facilitators to telepsychology use [22]. We used a blended deductive and inductive coding procedure [23,24]. The original 16 barrier categories and 15 facilitator categories were generated by researchers with extensive expertise in the field of telehealth technologies and relied on prior literature on the most frequently researched barriers and facilitators to telemedicine. This research framework was used to identify these categories, establish guidelines for the types of responses that would fall under each category, and appropriately code participant responses into the researcher generated categories. Further, an inductive coding approach was used to derive concepts and themes that extended beyond the original 31 researcher generated categories. This resulted in the addition of 2 barrier/deterrent categories and 1 advantage/facilitator category. The miscellaneous category was created for codes that did not fit into the main themes [25]. This residual category was used to house codes that were either deemed not common enough to generate a new thematic category or did not fit into the deductive categories in our coding framework. This method of categorizing codes has been used in previous studies on telehealth use [22].

The two initial raters were psychology PhD students familiar with the literature on telemedicine use and independently reviewed the 62 “Other [Please specify]” responses (20 advantages/facilitators and 42 barriers/deterrents). The two raters then reviewed the list of researcher-generated categories and created mutually agreed upon definitions for each category to assist in coding. The raters also generated two additional barrier/deterrent categories: “inadequate patient technological literacy” and “not suitable for certain patients or types of care” and one additional advantage/facilitator category: “miscellaneous.” Finally, one participant gave multiple “Other [Please specify]” responses which were separated into individual units of meaning for a final count of 63 “Other [Please specify]” responses with 20 advantages/facilitators and 43 barriers/deterrents. The final list of categories with the addition of the three categories created by the raters totaled 18 barriers and 16 facilitators (S1 Table).

The raters then coded the 63 “Other [Please specify]” responses resulting in an interrater reliability of 85.4%. Of the 63 “Other [Please specify]” responses, two advantages/disadvantages were removed as “nonsensical or unable to be coded.” One barrier/deterrent was also listed in the advantages/facilitators section; this response was also removed from the advantages/facilitators section. This resulted in 60 “Other [Please specify]” responses being coded into the 34 barrier and facilitator categories. A third independent rater who was also a psychology PhD student served as a tiebreaker for the items on which the first two raters did not agree, choosing only from the two categories endorsed by the first two raters. The final, tie-broken list was then reintegrated with the full list of responses obtained from the survey and analyzed. Example responses for the “Other” category are provided in S2 Table. The study’s anonymized data are available in S1 Data.

Results

The sample included 228 physicians who were an average of 46.14 years old (SD=10.12). A greater proportion of the physicians were women (64%), identified as White (75%), and were practicing in urban and suburban settings (92.5%). There was low racial/ethnic diversity among physicians and a low percentage of physicians working in rural areas. The sample characteristics are summarized in Table 1. The medical specialties reported by the physicians can be found in Table 2. Since the physicians were allowed to select more than one answer for the medical specialty question on the survey, the total number of responses exceed our sample size of 228.

Table 1. Sample Characteristics (N=228).

Characteristics (N=228)
Age M (SD) 46.14 (10.12)
Years in Practice M (SD) 18.32 (10.00)
Gender N, (%)
Man 82 (36%)
Woman 146 (64%)
Race/Ethnicity N, %
White/European-American 170 (75%)
Black/African-American 6 (2.6%)
Hispanic/Latino 9 (3.9%)
Asian/Asian-American 31 (13.6%)
Multiracial/Multiethnic 8 (3.5%)
Other 3 (1.3%)
American Indian/Alaska Native/Native American 1 (0.4%)
Geographic Setting of Practice N, %
Urban 152 (66.7%)
Suburban 59 (25.9%)
Rural 17 (7.5%)
Primary Practice Setting N, %
Hospital 58 (25.4%)
Veterans Affairs Medical Center 7 (3.1%)
Academic Medical Center 90 (39.5%)
Health Maintenance Organization 1 (0.4%)
Individual Practice 6 (2.6%)
Group Practice 33 (14.5%)
Outpatient Treatment Facility 7 (3.1%)
School/University 8 (3.5%)
Other 18 (7.9%)
Number of Providers in Practice N, %
One 8 (3.5%)
Two to Five 47 (20.6%)
Six to Ten 52 (22.8%)
Eleven to Twenty 29 (12.7%)
Twenty-one to Fifty 21 (9.2)
More than Fifty 70 (30.7)
Not Reported 1 (0.4%)

Table 2. Medical Specialties (N=258).

Medical Specialty (N=258)
Allergy and Immunology 4 (1.8%)
Anesthesiology 4 (1.8%)
Clinical Genetics and Genomics 1 (0.4%)
Colon and Rectal Surgery 1 (0.4%)
Diagnostic Radiology 3 (1.3%)
Emergency Medicine 18 (7.9%)
Family Medicine 21 (9.2%)
General Surgery 5 (2.2%)
Internal Medicine 34 (14.9%)
Interventional Radiology and Diagnostic Radiology 2 (0.9%)
Neurological Surgery 3 (1.3%)
Neurology 4 (1.8%)
Obstetrics and Gynecology 12 (5.3%)
Ophthalmology 8 (3.5%)
Orthopedic Surgery 2 (0.9%)
Otolaryngology – Head and Neck Surgery 9 (3.9%)
Pathology 3 (1.3%)
Pediatrics 56 (24.6%)
Physical Medicine and Rehabilitation 6 (2.6%)
Psychiatry 9 (3.9%)
Public Health and General Preventive Medicine 1 (0.4%)
Radiation Oncology 6 (2.6%)
Thoracic and Cardiac Surgery 2 (0.9%)
Vascular Surgery 1 (0.4%)
Other 43 (18.9%)

Participants could select all that apply, so the total frequency is greater than the sample size.

The most frequently endorsed barriers and facilitators can be seen in S3 Table. The five most frequently endorsed barriers were: lack of patient access to technology (endorsed by 77.6% of physicians), insufficient insurance reimbursement (53.5% of physicians), diminished doctor-patient relationship (46.9%), inadequate video/audio technology (46.1%), and diminished quality of delivered care (42.1%). The five most frequently endorsed facilitators were: better access to care (75.4%), increased safety (70.6%), efficient use of time (60.5%), lower cost for patients (43%), and effectiveness (28.9%). Logistic regressions were run only on the most frequently endorsed barriers and facilitators (20% or more), and these results can be seen in S4 Table and S5 Table, with overall model statistics presented in S6 Table.

Only two of the overall models were significant, the barrier of inefficient use of time (p < 0.001) and the facilitator of lower cost for patients (p = 0.002). Within the context of all other variables included in the models, older physicians were less likely to endorse inefficient use of time (p <.001 for the individual odds ratio) and potential for medical errors (p = 0.034) as barriers to telemedicine use compared to younger physicians. Physicians working in a medical center were more likely to endorse inadequate video/audio technology (p = 0.037) and lack of patient access to technology (p = 0.035) as barriers compared to those working in other settings, and male physicians were more likely to endorse inefficient use of time (p = 0.007) as a barrier to telemedicine uptake than female physicians (S4 Table). White physicians were less likely to endorse lower cost to patients (p = 0.012) as a facilitator to telemedicine use than non-White physicians, whereas physicians working in a medical center (p = 0.041) were more likely to endorse lower cost to patients as a facilitator than physicians working in other settings (S5 Table).

Discussion

This study examined quantitative and qualitative data provided by 228 practicing physicians in the U.S. to identify barriers and facilitators to the adoption of telemedicine at the beginning of the COVID-19 pandemic. The top five endorsed barriers were: (1) lack of patient access to technology, (2) insufficient insurance reimbursement, (3) diminished doctor-patient relationship, (4) inadequate video/audio technology, and (5) diminished quality of delivered care. The top five endorsed facilitators were: (1) better access to care, (2) increased safety, (3) efficient use of time, (4) lower cost for patients, and (5) effectiveness. These findings are largely consistent with literature prior to the COVID-19 pandemic [11,12,14,15] and during the COVID-19 pandemic [10,16,17,26] and will add to the growing body of literature on providers’ perceptions of barriers and facilitators to telemedicine use. Some of the barriers (e.g., patients’ technology difficulty, limited physical examination due to virtual format) identified at the beginning of the pandemic [27,28] continued to be reported throughout the pandemic [2932]. Additionally, while there appeared to be increased concerns about the virtual format impacting provider-patient relationship [29,31,32], adequate telemedicine training and increased equipment accessibility were positively associated with telemedicine use [33]. Telemedicine has transformed the healthcare landscape in the wake of the COVID-19 pandemic [1012]. Sustained adoption of telemedicine is warranted, given it has been shown to improve healthcare access for underserved populations [34], reduce costs [35], and improve patient outcomes [36]. The immediate uptake and wide implementation of telemedicine during the COVID-19 pandemic were in part due to the removal of legislative restrictions and reimbursement constraints, highlighting the importance of having supportive policies in place to sustain the continued use of telemedicine [37,38].

The present study identified a number of important demographic and practice-related predictors of physicians’ perceptions of telemedicine use. The Nagelkerke pseudo-R2 statistics in the logistic regression models had a wide range, suggesting that the predictors explained 0.4%-14.8% of the variance in barrier endorsement and between 1.4%-11.0% of the variance in facilitator endorsement. As a result, these model effect sizes were largely in the small- (≤0.01) to medium- (≤0.09) sized range. Only two of the overall models including all relevant study predictors (age, gender, race, medical practice location, and urbanicity) were significant. The relatively low explanatory power of the models may be due to (a) a lack of critical predictors in the model, (b) low statistical power due to the smaller sample size, or (c) the inclusion of predictors that do not add significant explanatory power to the model. Thus, despite the relative lack of significance for the majority of the models, we examined the strength of individual predictors.

Within these models, older physicians reported fewer barriers to telemedicine than younger physicians, particularly inefficient use of time and potential for medical errors. It is possible that career stage might be the primary force behind these differences; however, no research to date has explored why this discrepancy might exist. Older physicians may have a more established caseload, regular patients, and greater experience navigating issues that arise due to treatment or telemedicine. Seniority may also come with additional benefits (e.g., better work schedule, supervisory roles) that may make the use of telemedicine more convenient.

Physicians working in a medical center were more likely to endorse inadequate video/audio technology as a barrier and more likely to endorse lower cost for patients as a facilitator than providers working in other settings. It is possible that physicians in medical centers may have trouble finding dedicated workspaces or tools for telemedicine appointments [16] or may be frustrated by a lack of resources during telemedicine appointments that would be available during a typical in-person appointment (e.g., imaging); however, no research to date has investigated this possibility. The likelihood to endorse lower cost to patients could be related to several factors including ancillary fees that are avoided when using telemedicine (parking, transportation, etc.) or possibly a reduced fee structure for telemedicine appointments.

Male physicians were more likely to endorse inefficient use of time as a barrier than female physicians. There is some research suggesting female providers also take longer on average with their patients than male providers [39], suggesting more willingness to have a longer patient encounter. The additional time needed to start a telemedicine appointment may be especially salient for male providers. Additional research on gender-based differences in telemedicine preference is severely lacking leaving us to hypothesize other possible explanations. Male physicians might generally prefer in-person visits or grow impatient more quickly with troubleshooting difficulties, resulting in a perception that telemedicine wastes time. Patient distractibility (e.g., providing care for a child while in a telemedicine appointment) may also be influencing the difference between male and female providers. It is possible that the way in which the telemedicine program is implemented may add additional burden to the process (e.g., a telemedicine clinic that enables providers from a major metropolitan medical center to treat patients who are still required to go in-person to a rural telemedicine medical center as opposed to a direct telemedicine to home program).

Finally, White physicians were less likely to endorse lower costs for patients as a facilitator. While the specific reason for this difference is unknown (and little research has been conducted that might provide meaningful insight), it is possible that White physicians might serve a more affluent clientele. Particularly if the provider is on retainer or the patient pays out of pocket, there might be little reason to see a significant difference in cost. This could also be a function of service area or practice setting with non-White physicians being more likely to work in community-based clinics or on a sliding scale.

This study was conducted during the pandemic public health emergency when there was a rapid uptake in telemedicine use; the state of telemedicine has changed much since then. While Medicare has permanently expanded telemedicine coverage for behavioral telehealth services, many telemedicine flexibilities were temporary and have expired [40]. Currently, telehealth regulations for private insurers vary state by state [41], and many private insurers have changed reimbursement policies around telemedicine despite adopting greater flexibility during the pandemic. These changes in reimbursement underline the importance of continued advocacy work to inform policy and legislative changes to improve the sustainability of telemedicine in a post-pandemic context.

Interestingly, in the present study, diminished quality of delivered care (38.60%) was one of the most endorsed barriers, and higher quality of delivered care (5.30%) was the least endorsed facilitator, suggesting that physicians were concerned about the quality of care delivered via telemedicine at the beginning of the pandemic. Their perception contrasts with telemedicine research on the lack of impact of digital care delivery on patient-provider alliance [42,43], patient perceptions of quality of care [44], physician perceptions of increasing satisfaction with telemedicine and quality of care [45], and higher continuity of care associated with telemedicine use especially for chronic disease management [46]. Thus, physician attitudes toward telemedicine may have shifted post-pandemic given the positive healthcare outcomes illustrated by digital care delivery during the pandemic. Additionally, offering tailored training programs and implementing appropriate telehealth technologies at work may mitigate resistance from physicians who are skeptical about the effectiveness of digital care delivery.

Digital literacy has been shown to be a social determinant of health affecting healthcare outcomes [47,48]. Greater digital literacy was associated with increased telehealth use during the pandemic [49]. Individuals from disadvantaged groups are more likely to experience reduced access to telemedicine as a result of decreased digital literacy [5052]. Targeted programs addressing digital health literacy skills may reduce disparities in telemedicine use by helping patients build necessary digital skills and improving equitable access to telemedicine [50]. To facilitate digital inclusion and bridge the digital divide, it is important to fund initiatives focusing on improving broadband infrastructure and increasing affordability of internet access [53].

Limitations and future directions

While the current study contributed several novel findings to the burgeoning telemedicine literature, it has some limitations. Since data were collected at the beginning of the COVID-19 pandemic, it is important to contextualize the findings and recognize the transformative role telemedicine played during this critical transition period for the healthcare field. As a result, generalizability of the findings is limited, as certain perceived barriers or facilitators identified by physicians at the beginning of the pandemic may be less relevant in the post-COVID era (e.g., virtual visits facilitated infection prevention and control). Thus, all results must be interpreted through the lens of the pandemic and its many challenges, and future research should be conducted to examine how telemedicine, its implementation, and demand for it may have changed.

Several groups of people were underrepresented in the current study. The sample was heavily White- (75%) and female- (64%) biased. Further, only 17 of the 228 physicians were practicing in a rural location, an area that often faces profound and unique challenges for telemedicine (e.g., internet access, poverty, lack of providers). The lack of response from rural providers made the grouping of practice location (urban vs suburban and rural) difficult. While the current study did not uncover a significant predictive relation between urbanicity and the various barriers and facilitators, it is possible that, had the rural sample been larger, we might have uncovered significant results for rurality (rural vs urban/suburban). Though the current study’s sampling process had a response rate comparable to many similar studies, certain groups of physicians may have been more likely to complete the study, such as those with more flexible time to do so, those whose email addresses were a part of common medical listservs, and those who were scientifically minded and open to participating in research. Future studies should include a larger more diverse sample with multiple sampling approaches (e.g., in person, physical mail, advertisements, etc.) to aid in generalizability.

It is quite possible the use of telemedicine may face unique difficulties with certain patient populations, treatment modalities, or therapeutic techniques (and this was indeed noted in several of the “Other [Please specify]” responses). Recent studies have shown that the uptake of telemedicine varies by specialty [54] and clinical conditions [55]. While the current study did collect data on provider specialty, it was difficult to classify specialties meaningfully for the statistical analyses due to the diversity of specialties represented by the sample. Future studies examining barriers and facilitators to telemedicine uptake should consider provider specialty to assist in targeted programs to increase telemedicine use where it may be more difficult to implement but still beneficial for patients.

Another limitation of the study is that participants’ free text responses were integrated into the existing themes, which impacted the richness and nuances of the qualitative findings. For example, while inadequate technological literacy was not listed in the survey as a barrier for physicians to choose from, it does not mean that this barrier was not perceived as important by the physicians; if it were presented in the survey, some physicians might have selected it. Future research may consider conducting qualitative interviews with physicians to examine their perceptions and opinions of telemedicine use with a focus on the impacts of the digital divide on access to telemedicine.

This study returned a number of non-significant predictors of barriers and facilitators to telemedicine uptake. There could be manifold reasons for the lack of significant findings including a true lack of effect, poor statistical power, item or scale constructs may have inherent measurement error due to imprecise wording, or there may be additional unknown methodological confounds obscuring real results. Future research may wish to investigate these predictors in a larger sample with greater power. It is possible that with a larger or more diverse sample, results might be different, with some additional categories being significantly endorsed, although the effect sizes likely would have been small-sized and possibly not as robust or important as those found in the current study. This study focused only on physicians; however, patient care is frequently multidisciplinary, multimodal, and team-based. Thus, future research, particularly for group practices, hospitals, medical centers, or other healthcare institutions with large teams of providers, should include a more diverse group that is representative of the multidimensionality of healthcare (e.g., nurses, allied health professionals, psychologists) which might also provide the ability to gather a much larger sample.

Finally, the research on barriers and facilitators to telehealth is still in its relative infancy, especially after the COVID-19 transformation of telehealth services. This study highlighted a number of gaps in the literature regarding what might underpin provider suspicion of or affinity for telemedicine. Future research may wish to examine, for instance, why male providers perceive of telemedicine as an inefficient use of time or whether physicians believe telemedicine appointments routinely lack vital resources that might be available for in-person visits.

Conclusion

This study examined quantitative and qualitative data provided by 228 practicing physicians in the U.S. to identify barriers and facilitators to telemedicine uptake during the beginning of the COVID-19 pandemic. Physicians endorsed lack of patient access to telemedicine technology as the primary barrier to telemedicine use and increased access to care as the primary facilitator. The current study also identified seven other frequently endorsed barriers and seven other frequently endorsed facilitators as areas for targeted intervention to assist in the implementation of telemedicine. Additionally, the current study uncovered several important demographic and practice characteristics for predicting the likelihood to endorse a particular barrier or facilitator during the beginning of the COVID-19 pandemic. These results contribute to the growing literature on telemedicine uptake and implementation, highlighting the profound need for continued research on how telemedicine may be perceived or implemented across specialties, patient populations, and treatment modalities. Since the expansion in telemedicine use will continue to influence care provision beyond the pandemic, future research should examine perceived post-pandemic barriers and facilitators of telemedicine use and develop strategies to address personal and systemic barriers and support delivery of patient-centered care via telemedicine.

Supporting information

S1 Table. Final list of barriers and facilitators.

(DOCX)

pdig.0000818.s001.docx (16KB, docx)
S2 Table. Sample “Other” responses.

(DOCX)

pdig.0000818.s002.docx (14KB, docx)
S3 Table. Percentage endorsed of each telemedicine barrier and facilitator.

(DOCX)

pdig.0000818.s003.docx (16.5KB, docx)
S4 Table. Variables in logistic regressions for barriers.

(DOCX)

pdig.0000818.s004.docx (18KB, docx)
S5 Table. Variables in logistic regressions for facilitators.

(DOCX)

pdig.0000818.s005.docx (17.8KB, docx)
S6 Table. Chi-squared and Nagelkerke pseudo-R squared.

(DOCX)

pdig.0000818.s006.docx (14.7KB, docx)
S1 Data. Publicly available data file.

(SAV)

pdig.0000818.s007.sav (306.7KB, sav)

Data Availability

Data are publicly available as a supplementary attachment to this manuscript.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. [Internet]. [cited 2024 Jul 17]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [Google Scholar]
  • 2.World Health Organization. Pass the message: Five steps to kicking out coronavirus [Internet]. [cited 2024 Jul 17]. Available from: https://www.who.int/news/item/23-03-2020-pass-the-message-five-steps-to-kicking-out-coronavirus [Google Scholar]
  • 3.Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID-19. J Allergy Clin Immunol Pract. 2020;8(5):1489–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.American College of Surgeons. COVID-19: Recommendations for Management of Elective Surgical Procedures [Internet]. Available from: https://www.facs.org/media/b04pkoxp/recommendations_for_management_of_elective_surgical_procedures.pdf [Google Scholar]
  • 5.Health and Human Services. Why use telehealth?. Telehealth.HHS.gov [Internet]. [cited 2023 Apr 20]. Available from: https://telehealth.hhs.gov/patients/why-use-telehealth [Google Scholar]
  • 6.Nitkin K. In Fight Against Coronavirus, Telemedicine Ramps Up at Johns Hopkins [Internet]. [cited 2024 Jul 17]. Available from: https://www.hopkinsmedicine.org/news/articles/2020/03/telemedicine [Google Scholar]
  • 7.Stiepan D. How video appointments are changing the way Mayo Clinic patients receive care [Internet]. Mayo Clinic News Network. 2020. [cited 2024 Jul 17]. Available from: https://newsnetwork.mayoclinic.org/discussion/how-video-appointments-are-changing-the-way-mayo-clinic-patients-receive-care/ [Google Scholar]
  • 8.Veterans Health Administration. Office of Emergency Management. COVID-19 Response Plan [Internet]. Available from: https://www.va.gov/opa/docs/VHA_COVID_19_03232020_vF_1.pdf [Google Scholar]
  • 9.Koonin L, Hoots B, Tsang C, Leroy Z, Farris K, Jolly T, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic - United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595–9. doi: 10.15585/mmwr.mm6943a3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pierce B, Perrin P, Dow A, Dautovich N, Rybarczyk B, Mishra V. Changes in physician telemedicine use during COVID-19: Effects of practice setting, demographics, training, and organizational policies. International Journal of Environmental Research and Public Health. 2021;18(19):9963. doi: 10.3390/ijerph18199963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.McClellan MJ, Florell D, Palmer J, Kidder C. Clinician telehealth attitudes in a rural community mental health center setting. Journal of Rural Mental Health. 2020;44(1):62–73. doi: 10.1037/rmh0000127 [DOI] [Google Scholar]
  • 12.Sisk B, Alexander J, Bodnar C, Curfman A, Garber K, McSwain SD, et al. Pediatrician Attitudes Toward and Experiences With Telehealth Use: Results From a National Survey. Acad Pediatr. 2020;20(5):628–35. doi: 10.1016/j.acap.2020.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Taylor J, Coates E, Brewster L, Mountain G, Wessels B, Hawley MS. Examining the use of telehealth in community nursing: identifying the factors affecting frontline staff acceptance and telehealth adoption. J Adv Nurs. 2015;71(2):326–37. doi: 10.1111/jan.12480 [DOI] [PubMed] [Google Scholar]
  • 14.Guise V, Wiig S. Perceptions of telecare training needs in home healthcare services: a focus group study. BMC Health Serv Res. 2017;17(1):164. doi: 10.1186/s12913-017-2098-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gray M, Hassija C, Jaconis M, Barrett C, Zheng P, Steinmetz S. Provision of evidence-based therapies to rural survivors of domestic violence and sexual assault via telehealth: Treatment outcomes and clinical training benefits. Training and Education in Professional Psychology. 2015;9(3):235–41. [Google Scholar]
  • 16.Curfman A, McSwain S, Chuo J, Yeager-McSwain B, Schinasi D, Marcin J. Pediatric telehealth in the COVID-19 pandemic era and beyond. Pediatrics. 2021;148(3):e2020047795. doi: 10.1542/peds.2020-047795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Haque SN. Telehealth beyond COVID-19. Psychiatric Services. 2021;72(1):100–3. [DOI] [PubMed] [Google Scholar]
  • 18.Liu M, Wronski L. Examining completion rates in web surveys via over 25,000 real-world surveys. Soc Sci Comput Rev. 2018;36(1):116–24. [Google Scholar]
  • 19.Petrovcic A, Petrič G, Manfreda K. The effect of email invitation elements on response rate in a web survey within an online community. Computers in Human Behavior. 2016;56(1):320–9. [Google Scholar]
  • 20.RStudio Team. RStudio: Integrated Development for R. RStudio, PBC, Boston, MA [Internet]. 2020. Available from: http://www.rstudio.com/ [Google Scholar]
  • 21.Zhang Y, Wildemuth BM. Qualitative analysis of content. In: Wildemuth BM, editor. Applications of social research methods to questions in information and library science. Westport, Conn: Libraries Unlimited; 2009. p. 308–19. [Google Scholar]
  • 22.Watson J, Pierce B, Tyler C, Donovan E, Merced K, Mallon M. Barriers and facilitators to psychologists’ telepsychology uptake during the beginning of the COVID-19 pandemic. International Journal of Environmental Research and Public Health. 2023;20(8):5467. doi: 10.3390/ijerph20085467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Azungah T. Qualitative research: deductive and inductive approaches to data analysis. Qualitative Research Journal. 2018;18(4):383–400. [Google Scholar]
  • 24.Bingham A, Witkowsky P. Deductive and inductive approaches to qualitative data analysis. Analyzing and interpreting qualitative research: After the interview. 2021:133–46. [Google Scholar]
  • 25.Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77–101. [Google Scholar]
  • 26.Mazouri-Karker S, Lüchinger R, Braillard O, Bajwa N, Achab S, Hudelson P, et al. Perceptions of and Preferences for Telemedicine Use Since the Early Stages of the COVID-19 Pandemic: Cross-Sectional Survey of Patients and Physicians. JMIR Hum Factors. 2023;10:e50740. doi: 10.2196/50740 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Schinasi DA, Foster CC, Bohling MK, Barrera L, Macy ML. Attitudes and Perceptions of Telemedicine in Response to the COVID-19 Pandemic: A Survey of Naïve Healthcare Providers. Front Pediatr. 2021;9:647937. doi: 10.3389/fped.2021.647937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Terry DL, Buntoro SP. Perceived Usefulness of Telehealth Among Rural Medical Providers: Barriers to Use and Associations with Provider Confidence. J Technol Behav Sci. 2021. Dec 1;6(4):567–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abdelghany IK, AlMatar R, Al-Haqan A, Abdullah I, Waheedi S. Exploring healthcare providers’ perspectives on virtual care delivery: insights into telemedicine services. BMC Health Serv Res. 2024;24(1):1. doi: 10.1186/s12913-023-10244-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Alqahtani SS, Alraqi AD, Alageel AA. Physicians’ satisfaction with telehealth services among family physicians in Cluster 1 hospitals. J Family Med Prim Care. 2022;11(9):5563–8. doi: 10.4103/jfmpc.jfmpc_920_22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Aijaz M, Lewis V, Murray G. Advancing equity in challenging times: A qualitative study of telehealth expansion and changing patient–provider relationships in primary care settings during the COVID-19 pandemic. Digital Health. 2024;10(1):20552076241233148. doi: 10.1177/20552076241233148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Klee D, Pyne D, Kroll J, James W, Hirko KA. Rural patient and provider perceptions of telehealth implemented during the COVID-19 pandemic. BMC Health Serv Res. 2023;23(1):981. doi: 10.1186/s12913-023-09994-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Assaye BT, Belachew M, Worku A, Birhanu S, Sisay A, Kassaw M, et al. Perception towards the implementation of telemedicine during COVID-19 pandemic: a cross-sectional study. BMC Health Serv Res. 2023;23(1):967. doi: 10.1186/s12913-023-09927-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Fortney JC, Pyne JM, Turner EE, Farris KM, Normoyle TM, Avery MD, et al. Telepsychiatry integration of mental health services into rural primary care settings. Int Rev Psychiatry. 2015;27(6):525–39. doi: 10.3109/09540261.2015.1085838 [DOI] [PubMed] [Google Scholar]
  • 35.Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):e0170581. doi: 10.1371/journal.pone.0170581 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bashshur RL, Howell JD, Krupinski EA, Harms KM, Bashshur N, Doarn CR. The Empirical Foundations of Telemedicine Interventions in Primary Care. Telemed J E Health. 2016;22(5):342–75. doi: 10.1089/tmj.2016.0045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chen A, Ayub MH, Mishuris RG, Rodriguez JA, Gwynn K, Lo MC, et al. Telehealth Policy, Practice, and Education: a Position Statement of the Society of General Internal Medicine. J Gen Intern Med. 2023;38(11):2613–20. doi: 10.1007/s11606-023-08190-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.VanderWerf M, Bernard J, Barta DT, Berg J, Collins T, Dowdy M, et al. Pandemic Action Plan Policy and Regulatory Summary Telehealth Policy and Regulatory Considerations During a Pandemic. Telemed J E Health. 2022 Apr 1;28(4):457–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jefferson L, Bloor K, Birks Y, Hewitt C, Bland M. Effect of physicians’ gender on communication and consultation length: a systematic review and meta-analysis. J Health Serv Res Policy. 2013;18(4):242–8. doi: 10.1177/1355819613486465 [DOI] [PubMed] [Google Scholar]
  • 40.et al. Telehealth policy changes after the COVID-19 public health emergency [Internet]. [cited 2025 Jan 7]. Available from: https://telehealth.hhs.gov/providers/telehealth-policy/policy-changes-after-the-covid-19-public-health-emergency [Google Scholar]
  • 41.et al. Requirements for Private Payer Telehealth Reimbursement [Internet]. CCHP. [cited 2025 Jan 7]. Available from: https://www.cchpca.org/topic/requirements/ [Google Scholar]
  • 42.Elbin RJ, Stephenson K, Lipinski D, Maxey K, Womble MN, Reynolds E, et al. In-Person Versus Telehealth for Concussion Clinical Care in Adolescents: A Pilot Study of Therapeutic Alliance and Patient Satisfaction. J Head Trauma Rehabil. 2022;37(4):213–9. doi: 10.1097/HTR.0000000000000707 [DOI] [PubMed] [Google Scholar]
  • 43.Simpson SG, Reid CL. Therapeutic alliance in videoconferencing psychotherapy: a review. Aust J Rural Health. 2014;22(6):280–99. doi: 10.1111/ajr.12149 [DOI] [PubMed] [Google Scholar]
  • 44.Baughman DJ, Jabbarpour Y, Westfall JM, Jetty A, Zain A, Baughman K, et al. Comparison of Quality Performance Measures for Patients Receiving In-Person vs Telemedicine Primary Care in a Large Integrated Health System. JAMA Netw Open. 2022;5(9):e2233267. doi: 10.1001/jamanetworkopen.2022.33267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sengupta A, Sarkar S, Bhattacherjee A. The relationship between telemedicine tools and physician satisfaction, quality of care, and patient visits during the COVID-19 pandemic. Int J Med Inf. 2024;190:105541. [DOI] [PubMed] [Google Scholar]
  • 46.Tierney AA, Payán DD, Brown TT, Aguilera A, Shortell SM, Rodriguez HP. Telehealth Use, Care Continuity, and Quality: Diabetes and Hypertension Care in Community Health Centers Before and During the COVID-19 Pandemic. Med Care. 2023;61(Suppl 1):S62–9. doi: 10.1097/MLR.0000000000001811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Arias López MDP, Ong BA, Borrat Frigola X, Fernández AL, Hicklent RS, Obeles AJT, et al. Digital literacy as a new determinant of health: A scoping review. PLOS Digit Health. 2023;2(10):e0000279. doi: 10.1371/journal.pdig.0000279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sieck C, Sheon A, Ancker J, Castek J, Callahan B, Siefer A. Digital inclusion as a social determinant of health. Npj Digit Med. 2021;4(1):1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Le TV, Galperin H, Traube D. The impact of digital competence on telehealth utilization. Health Policy and Technology. 2023;12(1):100724. doi: 10.1016/j.hlpt.2023.100724 [DOI] [Google Scholar]
  • 50.Alon N, Perret S, Torous J. Working towards a ready to implement digital literacy program. mHealth. 2023;9. Available from: https://mhealth.amegroups.org/article/view/117085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Spanakis P, Lorimer B, Newbronner E, Wadman R, Crosland S, Gilbody S, et al. Digital health literacy and digital engagement for people with severe mental ill health across the course of the COVID-19 pandemic in England. BMC Med Inform Decis Mak. 2023;23(1):193. doi: 10.1186/s12911-023-02299-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Vitolo M, Ziveri V, Gozzi G, Busi C, Imberti J, Bonini N. DIGItal health literacy after COVID-19 outbreak among frail and non-frail cardiology patients: The DIGI-COVID study. Journal of Personalized Medicine. 2023;13(1):99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Rodriguez JA, Shachar C, Bates DW. Digital Inclusion as Health Care - Supporting Health Care Equity with Digital-Infrastructure Initiatives. N Engl J Med. 2022;386(12):1101–3. doi: 10.1056/NEJMp2115646 [DOI] [PubMed] [Google Scholar]
  • 54.Drake C, Lian T, Cameron B, Medynskaya K, Bosworth H, Shah K. Understanding telemedicine’s “new normal”: Variations in telemedicine use by specialty line and patient demographics. Telemedicine and e-Health. 2022;28(1):51–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Variation In Telemedicine Use And Outpatient Care During The COVID-19 Pandemic In The United States. Health Aff (Millwood). 2021;40(2):349–58. doi: 10.1377/hlthaff.2020.01786 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Digit Health. doi: 10.1371/journal.pdig.0000818.r002

Decision Letter 0

Calvin Or

12 Sep 2024

PDIG-D-24-00296

Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemic

PLOS Digital Health

Dear Dr. Perrin,

Thank you for submitting your manuscript to PLOS Digital Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Digital Health's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Nov 11 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at digitalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pdig/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Calvin Or, PhD

Section Editor

PLOS Digital Health

Journal Requirements:

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

--------------------

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

--------------------

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

--------------------

4. Is the manuscript presented in an intelligible fashion and written in standard English?<br/><br/>PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

--------------------

5. Review Comments to the Author<br/><br/>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This original research manuscript entitled “Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemic” is a well written manuscript assessing providers attitudes towards telepsychology. Overall, the findings from the study are important and quite relevant in the current healthcare climate. I generally think this manuscript is a good one, though there are a few questions that arise when reading it.

There are several points the investigative team should consider:

1/ Who were the physicians enrolled in the study? It is not entirely clear. There is a section on Table 1 that would discusses the primary practice setting, but I am unclear what the specialties were.

a/ The reason this is important is that other data have suggested that specialty area of practice has influenced the uptake of TH.

2/ The methods section is entirely too long and detracts from the findings of the manuscript. The investigative team should strongly consider revisions to this section. This is not a methods driven manuscript.

3/ The results section is a bit hard to get through with the embedded tables. But these tables are the actual important findings that should have a bit more text added to the results section.

4/ Given the uncertainty of the participant specialties, the conclusions may be a bit overly broad.

Reviewer #2: PDIG-D-24-00296

Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the

COVID-19 pandemic

This article surveyed a range of physicians in the US to determine their views on the use of telemedicine at the beginning of the COVID Pandemic. This is an important and relevant question as the role of telemedical consults has grown recently. Their questions were based on literature review and are appropriate. The sampling process to recruit subjects for the survey had limitations, although using a broader survey on mental health care to de-emphasize the telemedicine aspect could have strengthened the recruitment of a broader range of practitioners not just those interested in technology. Overall this paper includes valuable insights but there are a number of issues that need to be addressed.

Abstract:

Good, on first reading. Clear relevant points, not structured.

More information is needed on sampling methods, and lack of racial and ethnic representation.

Authors should include the statistical analyses used and the significant results found.

Introduction:

Good clear statement of research questions.

Survey was sent to 850 by email, 46 were undelivered, 315 opened survey, 228 with full data were included.

There was a low percentage of black and Latino physicians and those from rural areas.

Details of survey participants should be in the results section.

Survey occurred at the beginning of the COVID pandemic so likely reflected experiences before COVID and initial scale up with existing technologies.

Results:

Table 1:

Needs N in table

Percentages only need 1 decimal place

Percentage calculations are wrong, for example in section on Race/ethnicity and section on Primary Practice Setting

Full table needs to be recalculated and redesigned for clarity.

Survey questions appear appropriate with free text options

Table 2:

Structure needs to be improved to link titles and responses clearly (table lines?)

Response rate of 62/228 (27%) is relatively low.

The table is large and gives no indication of the frequency of different coded responses.

It would be clearer to summarize the most common types of free text responses in the results and include a full table of all responses and numbers in each category in an appendix.

Tables 4 and 5:

These tables are largely redundant as few of the odds ratios are significant at the P< .05 level. They should be summarized in the text or in much smaller tables that just highlight the significant values and perhaps indicates those that are of borderline significance. The full tables could be in appendices. It would be helpful to indicate to the reader that Exp(B) is the odds ratio.

Table 6:

This table only shows 2 statistically significant relationships and could be simplified with clear highlighting of the significant relationships, or moved to an appendix with significant results in the text.

Discussion:

Clear and helpful with important points about limitations to the survey.

The sampling process to recruit participants clearly had limitations in terms of responses. Do the authors have any evidence as to whether this may have favored certain groups?

Do the authors believe the results would be different 1-2 years after the start of the pandemic when the technology, training, experience and legal and economic structures had changed?

Limitations of the statistical analyses also need to be discussed particularly the relatively small sample size for the logistic regression analysis and the small number of statistically significant relationships.

Reviewer #3: Thank you for submitting your manuscript on barriers and facilitators to physicians' telemedicine uptake during the COVID-19 pandemic. Your study provides valuable insights into this very intense topic.

The mixed-methods approach and substantial sample size are strengths. However, there are several areas that require attention before publication. The structure could be improved by moving the explanation of survey options earlier in the methods section. The results presentation, particularly Table 4, is overwhelming and could benefit from a more digestible format, such as smaller tables or visual representations. While the discussion is comprehensive, it could be strengthened by more explicit connections to prior literature and deeper exploration of policy implications. The limitations section is candid but could further address how these limitations might influence result interpretation, especially regarding the COVID-19 context's impact on generalizability. Additionally, the low Nagelkerke pseudo-R squared values warrant more explicit discussion. Addressing these points will enhance the manuscript's clarity, rigor, and impact. We look forward to seeing a revised version that builds on the strong foundation you've established.

--------------------

<font color = "black">6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

--------------------

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Digit Health. doi: 10.1371/journal.pdig.0000818.r004

Decision Letter 1

Calvin Or

13 Dec 2024

PDIG-D-24-00296R1Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemicPLOS Digital Health Dear Dr. Perrin, Thank you for submitting your manuscript to PLOS Digital Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Digital Health's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 60 days Feb 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at digitalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pdig/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Calvin Or, PhDSection EditorPLOS Digital Health Calvin OrSection EditorPLOS Digital Health Leo Anthony CeliEditor-in-ChiefPLOS Digital Healthorcid.org/0000-0001-6712-6626 Additional Editor Comments (if provided):   [Note: HTML markup is below. Please do not edit.] Reviewers' Comments: Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: All comments have been addressed

Reviewer #5: (No Response)

Reviewer #6: All comments have been addressed

Reviewer #7: (No Response)

Reviewer #8: (No Response)

Reviewer #9: (No Response)

**********

2. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #4: Yes

Reviewer #5: Partly

Reviewer #6: Yes

Reviewer #7: Partly

Reviewer #8: Yes

Reviewer #9: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #7: Yes

Reviewer #8: Yes

Reviewer #9: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: No

Reviewer #5: (No Response)

Reviewer #6: Yes

Reviewer #7: Yes

Reviewer #8: Yes

Reviewer #9: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

Reviewer #5: (No Response)

Reviewer #6: Yes

Reviewer #7: Yes

Reviewer #8: Yes

Reviewer #9: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: Please add a statement about data availability. As mentioned in this journal, PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository.

Reviewer #5: This is an interesting manuscript that explores potential clinician-perceived barriers and facilitators or telehealth at the start of the pandemic. Although somewhat dated, it is still valuable to know what demographics may be particularly likely or unlikely to adopt telehealth to inform education efforts.

Previous reviewer comments on the unclear structure of the results and the inclusion of excessive detail have been satisfactorily addressed. However, some concerns remain to do with the relevance of findings in the 2025 context (and how well the discussion addresses this) and limitations of the qualitative approach.

The paragraph beginning with “Identifying the most and least endorsed barriers and facilitators can help inform institutional policies” requires more nuanced consideration given much has changed since the time of the survey. This should be a larger focus of the discussion, not just relegated to the limitations section. I’m aware that you also commented about the consistency of the findings during the pandemic, but post-pandemic there have been many changes in reimbursement, access to improved technology, improving digital literacy, literature on the lack of impact of digital delivery on quality of care or therapeutic alliance. Your discussion could be strengthened by consideration of which factors are likely to persist in the current environment as that will be more informative for the design of interventions.

Qualitative methodologies are broad and you have not specified what approach was used (thematic? Content?) or the coding approach taken (semantic? Inductive? Deductive?)? Which staff were raters? Without adequate description of the qualitative methods it is hard to judge quality and alignment with existing approaches.

It seems potentially problematic to simply recode the free text responses under the existing options - presumably, the respondents felt like these didn’t adequately capture their perspectives, hence they provided an “other” response. And this lacks some of the richness that would be expected of a qualitative report. I found the absence of example comments disappointing as they could provide useful elaboration, for example, on why the quality of care or the relationship was impacted. I’m not sure why the “miscellaneous” category was included, what does this add to the analysis when there is no coherent idea linking these responses?

A potential limitation is integrating the free text responses into the quantitative analysis. If a physicians didn’t mention, for example, inadequate patient technological literacy in a free text comment, it doesn’t mean they do not perceive this to be important. It may have simply meant they were not motivated enough or too time poor to comment. They may have selected these if they were presented in the survey. This may give the reader an inaccurate impression that this barrier was not perceived as important - rather, it was not asked after. This should be acknowledged as a limitation especially in light of literature showing the impacts of the digital divide on access to healthcare.

Reviewer #6: Great work on addressing the comments and improving the readability of the paper!

Minor thoughts/questions:

* Participants (p. 7): What was the geographical focus of this study or what physicians in the USA did you invite to participate? - might be worth mentioning this first thing to not cause any confusion later on (since the N would be quite small for all US physicians).

* Procedures (p. 7): Since that's a short sub-section and somewhat overlaps with previous information, I wondered if it would be useful to merge this section with "participants"?

* Data Analysis (p. 8): What does "endorsing" barriers/facilitators mean? Merely selecting them in the survey (and those items that were not selected were automatically "not endorsed")?

* Results (p. 12): are the statistical measures you present a p-value for ORs? (e.g.: "Older physicians were less likely to endorse inefficient use of time (p < .001) and potential for medical errors (p = 0.034) as barriers to telemedicine use compared to younger physicians." - it might be worth mentioning the measurement as they are part of the supplementary material but not the "main paper".

* Discussion (p. 18): Personal request: Would you mind mentioning "allied health professionals" instead of singling out PTs in the last sentence of the discussion?

Reviewer #7: Thank you for the opportunity to review this manuscript describing barriers and facilitators for the use of telemedicine by physicians at the beginning of the COVID-19 pandemic. The authors have tackled an important topic, provided a strong rationale for the investigation, and thoughtful discussion of the implication of results. They have improved this manuscript through revisions and suggestions from reviewers and it appears easier to read and understand findings. Although I do believe this manuscript overall would add to the body of literature for this topic, I believe that there are several areas that could be revised to enhance clarity and ensure the manuscript accurately reflects the findings, given the statistical analyses used. Thus, my comments are largely focused on the results section and ensuring that significant findings are appropriately explained in the context of all analyses conducted. I believe these revisions will strengthen the manuscript and allow readers to better interpret these findings. Below, I have provided detailed feedback organized by section for the authors.

Introduction/Discussion

- The introduction may benefit from slight restructure to include the importance of telemedicine and factors associated with sustained use (lines 97 through 103) prior to review of barriers and facilitators of use (lines 88 through 96). This would help improve and establish the rationale for examining these factors and their importance (even as we move into “post” COVID-19 healthcare).

Methods

- Do you have more information regarding the sampling procedures used? I wonder what percentage of the 850 recruitment announcements sent were individuals identified through hospital and health clinic websites and were these hospitals national or local to the researcher’s institution? How were these hospitals and health clinics selected? This may help explain and understand the physician characteristics and help understand generalizability to other physicians in the United States.

Results

- What does it mean if the omnibus binary logistic regressions were not significant? Does that impact interpretation of the predictors?

- Given these are multivariable logistic regressions, statements of results and significance of variables (e.g., age) should be stated “within the context of all other variables included in the model”.

- There were 16 separate logistic regressions run in this study. 4 out 8 barrier analyses yielded no significant results and 7 of 8 facilitator analyses yielded no significant results. Please add explanation to the results section detailing null findings and comment in the discussion as to why these predictors may not have explained variation in endorsement of a particular barrier/facilitator.

Discussion

- Be careful with language on line 236. It seems like identifying barriers and facilitators could inform institutional policies aimed at increasing adoption or sustainment of use of telemedicine… but I’m not sure about funding.

- The interpretation of the Nagelkerke pseudo-R2 statistics (lines 251 through 253) is misleading, as only two models were significant (and meaningfulness is up for interpretation or defense). This should be revised to be more accurate.

Tables

- Table S1 is still confusing, particularly the note. The table displays all codes used in the study, but the note makes it appear that these were all generated based on qualitative responses. Consider providing a general description of table and then specific notes including more information for clarity (e.g., “Descriptions of barriers and facilitators created based on research team agreement. Physicians’ “other” responses resulted in 20 facilitators and 43 barriers that were coded into the following categories: lack of patient access (n = 9), …”).

- Denote on Table S1 the three categories added to the list of researcher-generated codes.

- Consider landscape format for Table S1, consistency in text alignment within cells, and adding spacing to increase readability.

Reviewer #8: This paper provides useful insight into the barriers and facilitators, and contextual characteristics influencing these factors, associated with telemedicine use in the US. The authors have addressed reviewer comments well however, some revisions to reviewer comments could be addressed better and there are a couple of minor additional points that should be considered.

1) Addressing previous reviewer comments:

a) while the methods section has been slightly shortened, the description of the qualitative analysis could be further shortened/clarified to explain what the raters did i.e. what qualitative analysis strategy did the authors use? Looking at the reference it seems to be a qualitative content analysis. This could be presented much more simply e.g. the raters conducted independent content analysis to identify and categorise additional barriers/facilitators. Also the results of this qualitative analysis should be presented in the results rather than the methods.

b) the authors have moved the main results tables to supplementary materials per previous reviewers comments that the tables were too long, however now there are no main results tables presented in the results section. It would be useful to have a shorter table to substantiate claims on some of the main/significant findings (e.g. S2), and then the supplementary materials could be referenced for full results.

2) Additional points relating to methods (data analysis section):

a) the grouping of practice characteristics requires further explanation/justification. For medical centers vs other settings, please clarify what the definition of medical centers was in the current study e.g. was a hospital considered a medical center? For urban vs suburban and rural settings, please either justify why suburban and rural were grouped or perhaps consider referencing the grouping of these settings as a limitation. Typically, urban and suburban would be grouped as rural settings possess unique characteristics. Also, the results could highlight that there were no stat significant results for urban vs suburban and rural (and limitations could highlight that this could be due to the urban/suburban not being much different contextually).

b) Additionally, the data analysis section does not describe why chi squared tests and Nagelkerke pseudo-R squared were run, some brief additional detail on this would be useful.

Reviewer #9: This study examines telemedicine adoption during the COVID-19 pandemic, a critical period of healthcare transformation. The analysis of key barriers and facilitators offers practical insights for healthcare policy and telemedicine implementation strategies. However, the manuscript requires significant revisions before it can be considered for publication:

Logistic Regression Models

- The paper does not adequately explain why specific variables were chosen for the logistic regression models, weakening the rationale behind the analysis.

- The logistic regression models have low explanatory power (e.g., low Nagelkerke pseudo-R² values), indicating that critical factors influencing barriers and facilitators might be missing.

- Important variables such as years in practice, the number of providers in a practice, and additional practice settings were not included, despite their potential relevance to telemedicine adoption.

- The authors should incorporate these variables and explicitly justify their inclusion or exclusion.

Discussion Section

- The findings are not sufficiently grounded in prior literature, reducing the strength of the discussion.

- Specific Gaps in Citations:

Lines 221-227: No references are provided to support differences in telemedicine adoption between older and younger physicians.

Lines 232-236: The claim that physicians may be frustrated by the lack of in-person resources or that telemedicine reduces patient costs due to avoided ancillary fees lacks supporting citations.

Lines 240-248: While the authors appropriately cite literature on female providers spending more time with patients, they do not provide evidence for gender-based differences in telemedicine appointment durations or implementation challenges.

Minor Feedback

- Remove categories/levels with N=0, %=0 in Table 1 (e.g., Correctional Facility, Geriatric Facility).

- Separate Tables 4 and 5 into individual tables with titles reflecting outcomes (e.g., "Better Access to Care").

- Move chi-squared and Nagelkerke pseudo-R² values from Table 6 into corresponding tables for logistic regression results.

By addressing these issues, the manuscript will better justify its methodology, improve the integration of findings into existing literature, and enhance its clarity and impact.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: Yes: John Robert Bautista

Reviewer #5: No

Reviewer #6: No

Reviewer #7: No

Reviewer #8: No

Reviewer #9: No

**********

 [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLOS Digit Health. doi: 10.1371/journal.pdig.0000818.r006

Decision Letter 2

Calvin Or

8 Mar 2025

Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemic

PDIG-D-24-00296R2

Dear Dr. Perrin,

We are pleased to inform you that your manuscript 'Barriers and facilitators to physicians’ telemedicine uptake during the beginning of the COVID-19 pandemic' has been provisionally accepted for publication in PLOS Digital Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow-up email from a member of our team. 

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact digitalhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Digital Health.

Best regards,

Calvin Or, PhD

Section Editor

PLOS Digital Health

***********************************************************

Additional Editor Comments (if provided):

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #5: All comments have been addressed

Reviewer #6: All comments have been addressed

Reviewer #8: All comments have been addressed

**********

2. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #8: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #8: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #8: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #8: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #5: I'm satisfied that the authors have addressed the issues I and other authors previously commented on, by providing the required detail, or acknowledging the issue in the limitations.

Reviewer #6: (No Response)

Reviewer #8: Thank you for your responses and edits to the manuscript, reviewer comments have been thoroughly addressed and I have no further comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #5: No

Reviewer #6: No

Reviewer #8: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Final list of barriers and facilitators.

    (DOCX)

    pdig.0000818.s001.docx (16KB, docx)
    S2 Table. Sample “Other” responses.

    (DOCX)

    pdig.0000818.s002.docx (14KB, docx)
    S3 Table. Percentage endorsed of each telemedicine barrier and facilitator.

    (DOCX)

    pdig.0000818.s003.docx (16.5KB, docx)
    S4 Table. Variables in logistic regressions for barriers.

    (DOCX)

    pdig.0000818.s004.docx (18KB, docx)
    S5 Table. Variables in logistic regressions for facilitators.

    (DOCX)

    pdig.0000818.s005.docx (17.8KB, docx)
    S6 Table. Chi-squared and Nagelkerke pseudo-R squared.

    (DOCX)

    pdig.0000818.s006.docx (14.7KB, docx)
    S1 Data. Publicly available data file.

    (SAV)

    pdig.0000818.s007.sav (306.7KB, sav)
    Attachment

    Submitted filename: BF Physician Response Letter 09-24-24.docx

    pdig.0000818.s009.docx (24.5KB, docx)
    Attachment

    Submitted filename: BF Physician Response Letter 02-20-25.docx

    pdig.0000818.s010.docx (36.3KB, docx)

    Data Availability Statement

    Data are publicly available as a supplementary attachment to this manuscript.


    Articles from PLOS Digital Health are provided here courtesy of PLOS

    RESOURCES